| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |